Publications Office of the EU
Cyprus-Nicosia: Antineoplastic and immunomodulating agents - EU tenders
DisplayCustomHeader
MyPortal
Language Selector
English
BasketSummary
Procurement Detail Actions Portlet

Utilities

Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

Cyprus-Nicosia: Antineoplastic and immunomodulating agents

Overview
  • Awarded
    22/02/2023
  • Today
    18/06/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Υπουργείο Υγείας
Place of performance
NUTS code: CY000 Κύπρος
Location of buyer
NUTS code: CY Κύπρος (Kýpros)
Business sector (Main CPV)
33652000 Antineoplastic and immunomodulating agents
Total estimated contract value (excluding VAT)
1,930,485.00
Total final contract value (excluding VAT)
1,737,437.50 EUR
Procedure details
Tender reference number
Not available
Description

Supply "Vyvgart" vials

Submission Method
Not available
Tenders may be submitted
Not applicable
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
Not available
Conditions for opening tenders (date)
Not available
Place of performance
CY000 Κύπρος
CPV code

33652000 - Antineoplastic and immunomodulating agents

Award method
Lowest price
Estimated value
1,930,485.00
Final contracted value
1,737,437.50 EUR
Award of contract
Official name: Medison Pharma Trading AG
Postal address: Bahnhofstrasse 18
Town: Zug
Postal code: 6300
Country: CHE
Documents
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.